Sesen Bio Inc. (NASDAQ:SESN) price is hovering lower on Monday, September 13, dropping -1.07% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $0.94, with intraday deals fluctuating between $0.917 and $0.982. The company’s 5Y monthly beta was ticking 0.50. Taking into account the 52-week price action we note that the stock hit a 52-week high of $6.04 and 52-week low of $0.70. The stock subtracted -80.89% on its value in the past month.
Sesen Bio Inc., which has a market valuation of $185.01 million, is expected to release its quarterly earnings report Nov 08, 2021 – Nov 12, 2021. Analysts tracking SESN have forecast the quarterly EPS to shrink by -0.07 per share this quarter, while the same analysts predict the annual EPS to hit -$0.62 for the year 2021 and up to -$0.37 for 2022. In this case, analysts estimate an annual EPS growth of -226.30% for the year and 40.30% for the next year.
The average estimate suggests sales growth for the quarter will likely fall by -95.30% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $7.06 million for the company’s annual revenue in 2021. Per this projection, the revenue is forecast to grow -37.20% below that which the company brought in 2021.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give SESN a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 3 analysts have assigned SESN a recommendation rating as follows: 2 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Sesen Bio Inc. (SESN) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Overweight, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that SESN’s price is at present -12.28% off the SMA20 and -66.38% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 30.40, with weekly volatility standing at 8.19%. The indicator jumps to 48.83% when calculated based on the past 30 days. Sesen Bio Inc. (NASDAQ:SESN)’s beta value is holding at 0.44, while the average true range (ATR) indicator is currently reading 0.32. Considering analysts have assigned the stock a price target range of $1.50-$8.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $4.17. Based on this estimate, we see that today’s price at last check is roughly -61.29% off the estimated low and -760.22% off the forecast high. Investors will no doubt be excited to see the share price fall to $3.00, which is the median consensus price, and at that level SESN would be -222.58% from recent price.
An analysis of the Sesen Bio Inc. (NASDAQ:SESN) stock in terms of its daily trading volume indicates that the 3-month average is 19.64 million.
Current records show that the company has 175.39M in outstanding shares. The insiders’ percentage holdings are 0.03% of outstanding shares while the percentage share held by institutions stands at 34.30%. But the -30.51% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.